+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Transdermal Diffusion Sampling System Market by Product Type, Application, Technology, Study Type, End User - Global Forecast to 2030- Product Image
Transdermal Diffusion Sampling System Market by Product Type, Application, Technology, Study Type, End User - Global Forecast to 2030- Product Image
Sale

Transdermal Diffusion Sampling System Market by Product Type, Application, Technology, Study Type, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 181 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6081257
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Pioneering Non-Invasive Delivery and Monitoring Systems

Transdermal diffusion sampling systems have emerged as a pivotal technology in the realm of non-invasive delivery and monitoring, redefining how active compounds permeate the skin barrier and enter systemic circulation. Driven by breakthroughs in micro-fabrication and bioengineering, these platforms enable precise control over dosage, sampling depth, and analyte recovery. This evolution has profound implications for pharmaceutical formulation development, cosmetic efficacy validation, and personalized medicine, creating a fertile landscape for innovation and investment.

This executive summary provides a distilled overview of the global transdermal diffusion sampling system market. It synthesizes critical insights on transformative industry shifts, the implications of newly enacted United States tariffs for 2025, granular segmentation trends across product types, applications, technologies, study methodologies, and end users, as well as regional performance and leading corporate strategies. By weaving together primary research interviews with secondary market data and regulatory analysis, this summary equips decision-makers with an authoritative perspective on current dynamics and future trajectories.

Transitioning from foundational definitions to strategic considerations, subsequent sections delve into the forces reshaping the competitive environment, the cost structures influenced by trade policy adjustments, and actionable recommendations. Readers will emerge with a clear understanding of how to leverage innovation, optimize supply chains, and drive growth in one of the most rapidly advancing sectors of drug delivery and diagnostics.

Technological, Regulatory, and Consumer Catalysts Converge

A wave of technological breakthroughs is accelerating the maturation of transdermal diffusion sampling systems. Innovations in microneedle fabrication have unlocked new possibilities for minimally invasive skin penetration, while advances in nanogel and hydrogel matrices ensure controlled release profiles and enhanced analyte capture. Concurrently, digital integration-linking microfluidic sampling patches to data analytics platforms-is empowering real-time monitoring and personalized dosing, signaling a paradigm shift in patient engagement and clinical trial design.

Regulatory bodies are adapting guidelines to accommodate these hybrid platforms, streamlining approval pathways for devices that combine diagnostic sampling with delivery functions. Harmonized standards for biocompatibility, sterility, and performance validation are emerging across key markets, reducing time-to-market and encouraging cross-industry collaborations between pharma developers, medical device manufacturers, and cosmetic formulators.

Consumer expectations are evolving in tandem, with heightened demand for minimally invasive options in both therapeutic and aesthetic domains. End users now seek solutions that offer comfort, convenience, and demonstrable efficacy. As the industry pivots toward wearable sampling and closed-loop delivery systems, these converging trends underscore a transformative period marked by accelerated research, regulatory alignment, and shifting user behaviors.

Navigating Elevated Costs Amid New Trade Barriers

The implementation of new United States tariffs in 2025 has introduced significant complexities to the transdermal diffusion sampling system supply chain. Key raw materials-ranging from specialty polymers used in patches to precision microneedle substrates-face increased import duties, elevating production costs for manufacturers that rely on global sourcing. Likewise, tariffs on analytical instrumentation and microfabrication equipment have amplified capital expenditure requirements, prompting many producers to reassess their procurement strategies.

These cost pressures are influencing pricing models across the value chain. Manufacturers are negotiating longer-term contracts with domestic suppliers to mitigate duty impacts, while some end users are exploring alternative technologies or regional providers to balance total cost of ownership. At the same time, service organizations responsible for ex vivo and in vitro study workflows are absorbing higher operational expenses, which may translate into incremental project fees or revised service agreements.

In response, forward-looking organizations are accelerating investments in near-shoring and vertical integration to enhance supply chain resilience. Collaborative partnerships between instrument suppliers and contract research organizations are emerging to share risks. By proactively aligning sourcing strategies with evolving tariff structures, industry stakeholders can preserve margins, stabilize pricing, and maintain continuity in innovation and development pipelines.

Unpacking Multidimensional Market Segments for Precision Targeting

A nuanced understanding of market segmentation is essential for targeting growth opportunities across diverse product, application, technology, study type, and end-user categories. In the realm of product innovation, gels-encompassing both hydrogel and nanogel formulations-continue to command market share due to their versatility in delivering controlled sampling and analyte binding capacity. Microneedle systems, subdivided into coated variants such as drug-coated and polymer-coated interfaces and hollow or solid constructs, represent the fastest-growing segment by enabling rapid penetration with minimal discomfort. Traditional ointments, including lipid-based and water-based formulations, remain integral for high-viscosity sampling scenarios, while matrix and reservoir patches offer standardized dosage forms with scalable manufacturing processes.

In application domains, pharmaceutical development dominates demand as companies leverage these platforms for preclinical and clinical trials, supported by escalating interest in personal care products that integrate diffusion sampling for efficacy claims in both color cosmetics and haircare segments. The skincare sector is also embracing these technologies to substantiate anti-aging and dermatological benefits. Technologically, iontophoresis methods founded on electroosmosis and galvanophoresis are establishing benchmarks for passive diffusion enhancement, complemented by sonophoresis techniques operating at both high and low frequencies. Meanwhile, passive diffusion and permeation systems continue to serve as foundational approaches for basic research and comparative studies.

Study methodologies further refine market focus through ex vivo testing on animal and human skin samples, in vitro evaluations using both Franz cell and skin-on-chip platforms, and in vivo trials conducted on animal models-particularly rabbits and rats-alongside human volunteer studies. Finally, end users span a wide spectrum, from large and small contract research organizations to community and teaching hospitals, branded and generic pharmaceutical companies, and academic or government research institutes. By aligning product portfolios, regulatory strategies, and service offerings with these differentiated segments, stakeholders can optimize resource allocation and maximize market penetration.

Diverse Regional Drivers Shape Market Trajectories

Regional dynamics underscore the heterogeneous nature of global demand and innovation diffusion. In the Americas, a well-established pharmaceutical and medical device infrastructure supports robust adoption of advanced sampling systems. Research hubs in North America accelerate collaboration among CROs, academic institutions, and life sciences corporations, driving continuous product enhancement and application diversification.

Across Europe, the Middle East, and Africa, regulatory harmonization under frameworks such as CE marking and evolving guidelines from pan-European agencies foster a stable environment for device certification. Although cost containment pressures challenge pricing strategies, manufacturers benefit from a mature market that rewards validated efficacy and quality standards, particularly in skincare and personal care innovations.

The Asia-Pacific region is witnessing the most accelerated expansion, propelled by growing healthcare expenditures, rising prevalence of chronic diseases, and a burgeoning cosmetics market in key emerging economies. Governments are incentivizing domestic production capabilities through subsidy programs and public-private partnerships. As a result, both local and multinational players are intensifying investments in manufacturing scale-up and tailored service models to address region-specific demands.

Competitive Strategies Fueling Market Leadership

Competitive dynamics are characterized by a mix of legacy instrument providers and agile specialists advancing both hardware and consumables. Leading companies are forging strategic alliances to integrate microfabrication, microfluidics, and analytical software into cohesive platforms. Some have expanded their footprints through targeted acquisitions of niche technology developers, thereby bolstering their end-to-end service capabilities. Others focus on licensing agreements to incorporate proprietary gel and patch chemistries into broader device ecosystems.

Innovation leadership is increasingly determined by the ability to deliver turnkey solutions that encompass sampling modules, data analytics, and regulatory support. Market entrants with expertise in digital health are collaborating with established players to embed connectivity features and cloud-based dashboards. Meanwhile, global contract research organizations are differentiating by offering bundled service packages that span ex vivo, in vitro, and in vivo study protocols under one roof. Understanding these strategic moves enables stakeholders to benchmark performance and anticipate competitor offerings.

Strategic Roadmap for Sustainable Growth and Differentiation

Industry leaders should prioritize dual investments in product innovation and supply chain resilience to sustain momentum. Advancing microneedle and hydrogel formulations that enhance user comfort and sampling precision will differentiate offerings in crowded markets. Simultaneously, establishing reliable domestic and near-shore sourcing partnerships can mitigate the impact of trade policy volatility and accelerate time-to-market.

Engaging proactively with regulatory agencies to co-create validation frameworks will streamline approval processes and enhance credibility across regions. Leaders must also harness digital integration by embedding real-time analytics and connectivity into sampling platforms, thus unlocking new applications in remote patient monitoring and decentralized clinical trials.

Finally, forging cross-sector alliances-linking pharmaceutical developers, cosmetic brands, and technology vendors-will facilitate holistic solution development. By aligning product roadmaps with segmented end-user requirements and regional market conditions, organizations can capture emerging opportunities and drive sustainable growth.

Rigorous Multi-Source Methodology Underpinning Insights

This research leverages a mixed-methods approach combining extensive primary interviews with senior stakeholders, including product development scientists, regulatory specialists, and commercial leaders. These qualitative insights were complemented by a thorough review of secondary sources such as peer-reviewed publications, patent filings, technical white papers, and global regulatory guidelines. Market activity was mapped using deal databases and industry conference proceedings to capture partnership and acquisition trends.

Quantitative data was triangulated across proprietary surveys, shipment statistics, and regional import/export records to ensure robustness. Segmentation analyses were structured around five dimensions-product type, application, technology, study type, and end user-providing granular visibility into demand patterns. Regional breakdowns adhere to established economic zones to facilitate comparative assessments.

Rigorous data validation protocols were applied, including cross-checking key metrics with third-party research firms and validating assumptions through expert panels. This comprehensive methodology underpins the reliability of insights and recommendations, ensuring stakeholders can make informed strategic decisions with confidence.

Charting a Path Through Complexity to Market Success

The transdermal diffusion sampling system market stands at an inflection point, shaped by rapid technological evolution, shifting trade policies, and dynamic regional opportunities. As precision delivery and diagnostic integration gain prominence, stakeholders must navigate increasing complexity in regulatory alignment, supply chain structures, and customer expectations.

By synthesizing segmentation insights, tariff implications, and regional performance, this executive summary underscores the strategic imperatives for innovation, collaboration, and operational agility. Market participants who align their capabilities with nuanced segment and regional needs will be best positioned to capture value and drive the next wave of growth.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Gels
      • Hydrogel
      • Nanogel
    • Microneedles
      • Coated
        • Drug Coated
        • Polymer Coated
      • Hollow
      • Solid
    • Ointments
      • Lipid Based
      • Water Based
    • Patches
      • Matrix
      • Reservoir
  • Application
    • Cosmetics
      • Color Cosmetics
      • Haircare
      • Skincare
    • Personal Care
    • Pharmaceutical
  • Technology
    • Iontophoresis
      • Electroosmosis
      • Galvanophoresis
    • Microneedle Assisted
      • Dissolving
      • Solid
    • Passive
      • Diffusion
      • Permeation
    • Sonophoresis
      • High Frequency
      • Low Frequency
  • Study Type
    • Ex Vivo
      • Animal Skin
      • Human Skin
    • In Vitro
      • Franz Cell
      • Skin On Chip
    • In Vivo
      • Animal
        • Rabbit
        • Rat
      • Human
  • End User
    • CROs
      • Large
      • Small
    • Hospitals
      • Community
      • Teaching
    • Pharma Companies
      • Branded
      • Generic
    • Research Institutes
      • Academic
      • Government
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Agilent Technologies, Inc.
  • Merck KGaA
  • PerkinElmer, Inc.
  • Harvard Bioscience, Inc.
  • PermeGear, Inc.
  • Hanson Research Corporation
  • Copley Scientific Ltd.
  • Sotax AG
  • Pharma Test GmbH
  • Logan Instrument Company, Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Transdermal Diffusion Sampling System Market, by Product Type
8.1. Introduction
8.2. Gels
8.2.1. Hydrogel
8.2.2. Nanogel
8.3. Microneedles
8.3.1. Coated
8.3.1.1. Drug Coated
8.3.1.2. Polymer Coated
8.3.2. Hollow
8.3.3. Solid
8.4. Ointments
8.4.1. Lipid Based
8.4.2. Water Based
8.5. Patches
8.5.1. Matrix
8.5.2. Reservoir
9. Transdermal Diffusion Sampling System Market, by Application
9.1. Introduction
9.2. Cosmetics
9.2.1. Color Cosmetics
9.2.2. Haircare
9.2.3. Skincare
9.3. Personal Care
9.4. Pharmaceutical
10. Transdermal Diffusion Sampling System Market, by Technology
10.1. Introduction
10.2. Iontophoresis
10.2.1. Electroosmosis
10.2.2. Galvanophoresis
10.3. Microneedle Assisted
10.3.1. Dissolving
10.3.2. Solid
10.4. Passive
10.4.1. Diffusion
10.4.2. Permeation
10.5. Sonophoresis
10.5.1. High Frequency
10.5.2. Low Frequency
11. Transdermal Diffusion Sampling System Market, by Study Type
11.1. Introduction
11.2. Ex Vivo
11.2.1. Animal Skin
11.2.2. Human Skin
11.3. In Vitro
11.3.1. Franz Cell
11.3.2. Skin On Chip
11.4. In Vivo
11.4.1. Animal
11.4.1.1. Rabbit
11.4.1.2. Rat
11.4.2. Human
12. Transdermal Diffusion Sampling System Market, by End User
12.1. Introduction
12.2. CROs
12.2.1. Large
12.2.2. Small
12.3. Hospitals
12.3.1. Community
12.3.2. Teaching
12.4. Pharma Companies
12.4.1. Branded
12.4.2. Generic
12.5. Research Institutes
12.5.1. Academic
12.5.2. Government
13. Americas Transdermal Diffusion Sampling System Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Transdermal Diffusion Sampling System Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Transdermal Diffusion Sampling System Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Agilent Technologies, Inc.
16.3.2. Merck KGaA
16.3.3. PerkinElmer, Inc.
16.3.4. Harvard Bioscience, Inc.
16.3.5. PermeGear, Inc.
16.3.6. Hanson Research Corporation
16.3.7. Copley Scientific Ltd.
16.3.8. Sotax AG
16.3.9. Pharma Test GmbH
16.3.10. Logan Instrument Company, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET MULTI-CURRENCY
FIGURE 2. TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET MULTI-LANGUAGE
FIGURE 3. TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY STUDY TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY STUDY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY GELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY HYDROGEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY NANOGEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY MICRONEEDLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY COATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY DRUG COATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY POLYMER COATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY COATED, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY HOLLOW, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY SOLID, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY LIPID BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY WATER BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY OINTMENTS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY MATRIX, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY RESERVOIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY COSMETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY COLOR COSMETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY HAIRCARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY SKINCARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PERSONAL CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY IONTOPHORESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY ELECTROOSMOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY GALVANOPHORESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY IONTOPHORESIS, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY MICRONEEDLE ASSISTED, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY DISSOLVING, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY SOLID, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY MICRONEEDLE ASSISTED, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PASSIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY DIFFUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PERMEATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PASSIVE, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY SONOPHORESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY HIGH FREQUENCY, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY LOW FREQUENCY, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY SONOPHORESIS, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY STUDY TYPE, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY EX VIVO, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY ANIMAL SKIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY HUMAN SKIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY EX VIVO, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY IN VITRO, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY FRANZ CELL, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY SKIN ON CHIP, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY IN VITRO, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY IN VIVO, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY ANIMAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY RABBIT, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY RAT, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY HUMAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY IN VIVO, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY CROS, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY LARGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY SMALL, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY CROS, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY COMMUNITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY TEACHING, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PHARMA COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY BRANDED, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY GENERIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PHARMA COMPANIES, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY ACADEMIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY GOVERNMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY COATED, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY OINTMENTS, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY IONTOPHORESIS, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY MICRONEEDLE ASSISTED, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PASSIVE, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY SONOPHORESIS, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY STUDY TYPE, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY EX VIVO, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY IN VITRO, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY IN VIVO, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY CROS, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PHARMA COMPANIES, 2018-2030 (USD MILLION)
TABLE 107. AMERICAS TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 108. AMERICAS TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY COATED, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY OINTMENTS, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 115. UNITED STATES TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. UNITED STATES TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 117. UNITED STATES TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 118. UNITED STATES TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY IONTOPHORESIS, 2018-2030 (USD MILLION)
TABLE 119. UNITED STATES TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY MICRONEEDLE ASSISTED, 2018-2030 (USD MILLION)
TABLE 120. UNITED STATES TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PASSIVE, 2018-2030 (USD MILLION)
TABLE 121. UNITED STATES TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY SONOPHORESIS, 2018-2030 (USD MILLION)
TABLE 122. UNITED STATES TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY STUDY TYPE, 2018-2030 (USD MILLION)
TABLE 123. UNITED STATES TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY EX VIVO, 2018-2030 (USD MILLION)
TABLE 124. UNITED STATES TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY IN VITRO, 2018-2030 (USD MILLION)
TABLE 125. UNITED STATES TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY IN VIVO, 2018-2030 (USD MILLION)
TABLE 126. UNITED STATES TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 127. UNITED STATES TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. UNITED STATES TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY CROS, 2018-2030 (USD MILLION)
TABLE 129. UNITED STATES TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 130. UNITED STATES TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PHARMA COMPANIES, 2018-2030 (USD MILLION)
TABLE 131. UNITED STATES TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 132. UNITED STATES TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 133. CANADA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 134. CANADA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 135. CANADA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 136. CANADA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY COATED, 2018-2030 (USD MILLION)
TABLE 137. CANADA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY OINTMENTS, 2018-2030 (USD MILLION)
TABLE 138. CANADA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 139. CANADA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. CANADA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 141. CANADA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 142. CANADA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY IONTOPHORESIS, 2018-2030 (USD MILLION)
TABLE 143. CANADA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY MICRONEEDLE ASSISTED, 2018-2030 (USD MILLION)
TABLE 144. CANADA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PASSIVE, 2018-2030 (USD MILLION)
TABLE 145. CANADA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY SONOPHORESIS, 2018-2030 (USD MILLION)
TABLE 146. CANADA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY STUDY TYPE, 2018-2030 (USD MILLION)
TABLE 147. CANADA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY EX VIVO, 2018-2030 (USD MILLION)
TABLE 148. CANADA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY IN VITRO, 2018-2030 (USD MILLION)
TABLE 149. CANADA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY IN VIVO, 2018-2030 (USD MILLION)
TABLE 150. CANADA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 151. CANADA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. CANADA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY CROS, 2018-2030 (USD MILLION)
TABLE 153. CANADA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 154. CANADA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PHARMA COMPANIES, 2018-2030 (USD MILLION)
TABLE 155. CANADA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 156. MEXICO TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 157. MEXICO TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 158. MEXICO TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 159. MEXICO TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY COATED, 2018-2030 (USD MILLION)
TABLE 160. MEXICO TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY OINTMENTS, 2018-2030 (USD MILLION)
TABLE 161. MEXICO TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 162. MEXICO TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. MEXICO TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 164. MEXICO TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 165. MEXICO TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY IONTOPHORESIS, 2018-2030 (USD MILLION)
TABLE 166. MEXICO TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY MICRONEEDLE ASSISTED, 2018-2030 (USD MILLION)
TABLE 167. MEXICO TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PASSIVE, 2018-2030 (USD MILLION)
TABLE 168. MEXICO TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY SONOPHORESIS, 2018-2030 (USD MILLION)
TABLE 169. MEXICO TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY STUDY TYPE, 2018-2030 (USD MILLION)
TABLE 170. MEXICO TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY EX VIVO, 2018-2030 (USD MILLION)
TABLE 171. MEXICO TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY IN VITRO, 2018-2030 (USD MILLION)
TABLE 172. MEXICO TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY IN VIVO, 2018-2030 (USD MILLION)
TABLE 173. MEXICO TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 174. MEXICO TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. MEXICO TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY CROS, 2018-2030 (USD MILLION)
TABLE 176. MEXICO TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 177. MEXICO TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PHARMA COMPANIES, 2018-2030 (USD MILLION)
TABLE 178. MEXICO TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 179. BRAZIL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 180. BRAZIL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 181. BRAZIL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 182. BRAZIL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY COATED, 2018-2030 (USD MILLION)
TABLE 183. BRAZIL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY OINTMENTS, 2018-2030 (USD MILLION)
TABLE 184. BRAZIL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 185. BRAZIL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. BRAZIL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 187. BRAZIL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 188. BRAZIL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY IONTOPHORESIS, 2018-2030 (USD MILLION)
TABLE 189. BRAZIL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY MICRONEEDLE ASSISTED, 2018-2030 (USD MILLION)
TABLE 190. BRAZIL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PASSIVE, 2018-2030 (USD MILLION)
TABLE 191. BRAZIL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY SONOPHORESIS, 2018-2030 (USD MILLION)
TABLE 192. BRAZIL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY STUDY TYPE, 2018-2030 (USD MILLION)
TABLE 193. BRAZIL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY EX VIVO, 2018-2030 (USD MILLION)
TABLE 194. BRAZIL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY IN VITRO, 2018-2030 (USD MILLION)
TABLE 195. BRAZIL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY IN VIVO, 2018-2030 (USD MILLION)
TABLE 196. BRAZIL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 197. BRAZIL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. BRAZIL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY CROS, 2018-2030 (USD MILLION)
TABLE 199. BRAZIL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 200. BRAZIL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PHARMA COMPANIES, 2018-2030 (USD MILLION)
TABLE 201. BRAZIL TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 202. ARGENTINA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 203. ARGENTINA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 204. ARGENTINA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 205. ARGENTINA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY COATED, 2018-2030 (USD MILLION)
TABLE 206. ARGENTINA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY OINTMENTS, 2018-2030 (USD MILLION)
TABLE 207. ARGENTINA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 208. ARGENTINA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. ARGENTINA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 210. ARGENTINA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 211. ARGENTINA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY IONTOPHORESIS, 2018-2030 (USD MILLION)
TABLE 212. ARGENTINA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY MICRONEEDLE ASSISTED, 2018-2030 (USD MILLION)
TABLE 213. ARGENTINA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PASSIVE, 2018-2030 (USD MILLION)
TABLE 214. ARGENTINA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY SONOPHORESIS, 2018-2030 (USD MILLION)
TABLE 215. ARGENTINA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY STUDY TYPE, 2018-2030 (USD MILLION)
TABLE 216. ARGENTINA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY EX VIVO, 2018-2030 (USD MILLION)
TABLE 217. ARGENTINA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY IN VITRO, 2018-2030 (USD MILLION)
TABLE 218. ARGENTINA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY IN VIVO, 2018-2030 (USD MILLION)
TABLE 219. ARGENTINA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 220. ARGENTINA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. ARGENTINA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY CROS, 2018-2030 (USD MILLION)
TABLE 222. ARGENTINA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 223. ARGENTINA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PHARMA COMPANIES, 2018-2030 (USD MILLION)
TABLE 224. ARGENTINA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY COATED, 2018-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY OINTMENTS, 2018-2030 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY IONTOPHORESIS, 2018-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY MICRONEEDLE ASSISTED, 2018-2030 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PASSIVE, 2018-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY SONOPHORESIS, 2018-2030 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY STUDY TYPE, 2018-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY EX VIVO, 2018-2030 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY IN VITRO, 2018-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY IN VIVO, 2018-2030 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY CROS, 2018-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PHARMA COMPANIES, 2018-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 250. UNITED KINGDOM TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 252. UNITED KINGDOM TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY COATED, 2018-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY OINTMENTS, 2018-2030 (USD MILLION)
TABLE 254. UNITED KINGDOM TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. UNITED KINGDOM TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 258. UNITED KINGDOM TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY IONTOPHORESIS, 2018-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY MICRONEEDLE ASSISTED, 2018-2030 (USD MILLION)
TABLE 260. UNITED KINGDOM TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PASSIVE, 2018-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY SONOPHORESIS, 2018-2030 (USD MILLION)
TABLE 262. UNITED KINGDOM TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY STUDY TYPE, 2018-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY EX VIVO, 2018-2030 (USD MILLION)
TABLE 264. UNITED KINGDOM TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY IN VITRO, 2018-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY IN VIVO, 2018-2030 (USD MILLION)
TABLE 266. UNITED KINGDOM TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 268. UNITED KINGDOM TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY CROS, 2018-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 270. UNITED KINGDOM TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PHARMA COMPANIES, 2018-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 272. GERMANY TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 273. GERMANY TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 274. GERMANY TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 275. GERMANY TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY COATED, 2018-2030 (USD MILLION)
TABLE 276. GERMANY TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY OINTMENTS, 2018-2030 (USD MILLION)
TABLE 277. GERMANY TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 278. GERMANY TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 279. GERMANY TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 280. GERMANY TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 281. GERMANY TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY IONTOPHORESIS, 2018-2030 (USD MILLION)
TABLE 282. GERMANY TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY MICRONEEDLE ASSISTED, 2018-2030 (USD MILLION)
TABLE 283. GERMANY TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY PASSIVE, 2018-2030 (USD MILLION)
TABLE 284. GERMANY TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY SONOPHORESIS, 2018-2030 (USD MILLION)
TABLE 285. GERMANY TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY STUDY TYPE, 2018-2030 (USD MILLION)
TABLE 286. GERMANY TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY EX VIVO, 2018-2030 (USD MILLION)
TABLE 287. GERMANY TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY IN VITRO, 2018-2030 (USD MILLION)
TABLE 288. GERMANY TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY IN VIVO, 2018-2030 (USD MILLION)
TABLE 289. GERMANY TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 290. GERMANY TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 291. GERMANY TRANSDERMAL DIFFUSION SAMPLING SYSTEM MARKET SIZE, BY CROS, 2018-2030 (USD MILLION)
TABLE 292.

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Transdermal Diffusion Sampling System market report include:
  • Agilent Technologies, Inc.
  • Merck KGaA
  • PerkinElmer, Inc.
  • Harvard Bioscience, Inc.
  • PermeGear, Inc.
  • Hanson Research Corporation
  • Copley Scientific Ltd.
  • Sotax AG
  • Pharma Test GmbH
  • Logan Instrument Company, Inc.

Related Topics

Related Reports

Drug Transdermal Diffusion Apparatus Market by Product Type, Application, End Use, Distribution Channel - Global Forecast to 2030 - Product Image

Drug Transdermal Diffusion Apparatus Market by Product Type, Application, End Use, Distribution Channel - Global Forecast to 2030

  • Report
  • 184 Pages
  • Global
From
Transdermal Skin Patches Market Size, Share, Trends and Forecast by Type, Distribution Channel, Application, and Region, 2025-2033 - Product Image

Transdermal Skin Patches Market Size, Share, Trends and Forecast by Type, Distribution Channel, Application, and Region, 2025-2033

  • Report
  • 147 Pages
  • Global
From
Transdermal Skin Patches Market by Types, Application, Distribution Channel, Region and Company Analysis 2025-2033 - Product Image

Transdermal Skin Patches Market by Types, Application, Distribution Channel, Region and Company Analysis 2025-2033

  • Report
  • 180 Pages
  • Global
From
Transdermal Drug Delivery System Market by Product Type, Active Ingredient, Application, Technology, End User, Delivery Mechanism - Global Forecast to 2030 - Product Image

Transdermal Drug Delivery System Market by Product Type, Active Ingredient, Application, Technology, End User, Delivery Mechanism - Global Forecast to 2030

  • Report
  • 195 Pages
  • Global
From
Transdermal Skin Patches Market Size, Share & Trends Analysis Report By Type (Multi-layer Drug-in-Adhesive), By Application (Pain Relief), By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Transdermal Skin Patches Market Size, Share & Trends Analysis Report By Type (Multi-layer Drug-in-Adhesive), By Application (Pain Relief), By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 170 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.